Wcm Investment Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Wcm Investment Management, LLC

$38.6 Billion
Q3 2024

A detailed history of Wcm Investment Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Wcm Investment Management, LLC holds 219,962 shares of ARWR stock, worth $4.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

219,962

Previous 229,261 4.06%

Holding current value

$4.57 Million

Previous $5.96 Million 28.53%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$19.36 - $29.54 $180,028 - $274,692	-9,299 Reduced 4.06%	219,962 $4.26 Million
Q2 2024 Jul 31, 2024	BUY	$21.87 - $28.24 $80,437 - $103,866	3,678 Added 1.63%	229,261 $5.96 Million
Q1 2024 Apr 25, 2024	BUY	$27.21 - $39.48 $1.43 Million - $2.08 Million	52,718 Added 30.5%	225,583 $6.45 Million
Q4 2023 Jan 29, 2024	BUY	$21.2 - $31.03 $437,462 - $640,304	20,635 Added 13.56%	172,865 $5.29 Million
Q3 2023 Oct 10, 2023	BUY	$26.2 - $36.08 $15,798 - $21,756	603 Added 0.4%	152,230 $4.09 Million
Q2 2023 Jul 14, 2023	BUY	$25.16 - $41.38 $257,084 - $422,820	10,218 Added 7.23%	151,627 $5.41 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $134,810 - $219,237	-5,693 Reduced 3.87%	141,409 $3.59 Million
Q4 2022 Feb 06, 2023	BUY	$28.0 - $40.56 $1.97 Million - $2.85 Million	70,282 Added 91.49%	147,102 $5.97 Million
Q3 2022 Oct 18, 2022	BUY	$29.63 - $48.31 $169,779 - $276,816	5,730 Added 8.06%	76,820 $2.56 Million
Q2 2022 Aug 09, 2022	SELL	$27.79 - $50.61 $1.89 Million - $3.44 Million	-68,017 Reduced 48.9%	71,090 $2.46 Million
Q1 2022 May 06, 2022	BUY	$39.62 - $69.97 $353,053 - $623,502	8,911 Added 6.84%	139,107 $6.4 Million
Q4 2021 Jan 26, 2022	BUY	$58.09 - $82.51 $630,566 - $895,646	10,855 Added 9.1%	130,196 $8.63 Million
Q3 2021 Nov 02, 2021	BUY	$58.38 - $84.96 $1.86 Million - $2.71 Million	31,909 Added 36.5%	119,341 $7.45 Million
Q2 2021 Aug 05, 2021	BUY	$62.15 - $90.32 $210,253 - $305,552	3,383 Added 4.03%	87,432 $7.24 Million
Q1 2021 May 13, 2021	SELL	$61.35 - $90.47 $4.16 Million - $6.14 Million	-67,846 Reduced 44.67%	84,049 $5.57 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $20,201 - $39,355	461 Added 0.3%	151,895 $11.7 Million
Q3 2020 Nov 06, 2020	BUY	$33.21 - $51.27 $130,780 - $201,901	3,938 Added 2.67%	151,434 $6.52 Million
Q2 2020 Aug 18, 2020	BUY	$26.12 - $43.27 $1.02 Million - $1.68 Million	38,863 Added 35.77%	147,496 $6.37 Million
Q1 2020 May 08, 2020	BUY	$20.56 - $63.12 $1.54 Million - $4.72 Million	74,723 Added 220.36%	108,633 $3.13 Million
Q4 2019 Feb 07, 2020	BUY	$28.14 - $73.01 $954,227 - $2.48 Million	33,910 New	33,910 $2.15 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.5M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.

Account

Wcm Investment Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History